Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

Aim: This study aimed to report the efficacy and safety of trans-arterial chemoembolization (TACE) plus lenvatinib and camrelizumab in patients with advanced hepatocellular carcinoma (HCC).Methods: This retrospective study enrolled 22 patients with advanced HCC from March 2018 to December 2019. All...

Full description

Bibliographic Details
Main Authors: Juanfang Liu, Zhen Li, Wenguang Zhang, Huibin Lu, Zhanguo Sun, Guozheng Wang, Xinwei Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
hepatocellular carcinoma
TACE
lenvatinib
camrelizumab
intervention therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.709060/full

Similar Items

Similar Items